Form 4: Tivic Health CEO Granted 85,000 Stock Options

Tivic Health Systems, Inc. CEO Jennifer Ernst was granted 85,000 employee stock options with a $3.32 exercise price, vesting over four years.

Summary

• Jennifer Ernst, Chief Executive Officer and Director of Tivic Health Systems, Inc. (TIVC), was granted 85,000 employee stock options.
• The options have an exercise price of $3.32 per share.
• The grant date for these options was August 6, 2025.
• The options are set to expire on August 5, 2035.
• The vesting schedule dictates that 50% of the options will vest upon the first anniversary of the grant date (August 6, 2026), with the remaining 50% vesting in twelve successive equal quarterly installments thereafter, leading to 100% vesting by the fourth anniversary of the grant date (August 6, 2029).

Sentiment

Score: 7

Explanation: The grant of stock options to the CEO is a positive signal for management alignment and retention, though it introduces potential future dilution. It's a standard compensation practice.

Positives

• The grant of stock options aligns the Chief Executive Officer's interests directly with shareholder value creation.
• This equity incentive serves as a long-term retention mechanism for key management personnel.

Negatives

• The future exercise of these options could lead to dilution of existing shareholder equity.

Future Outlook

The vesting schedule outlines the future timeline for the CEO to gain full ownership of the granted options, aligning her incentives with long-term company performance.

Industry Context

This filing details a standard equity compensation grant to a senior executive, a common practice across industries to incentivize long-term performance and retention.

Comparison to Industry Standards

• The grant of stock options to a Chief Executive Officer is a common form of executive compensation across publicly traded companies, aiming to align executive interests with shareholder value.
• The vesting schedule, with a significant portion vesting after the first year and full vesting over four years, is typical for long-term incentive plans in the technology and healthcare sectors, comparable to practices at companies like Medtronic or Intuitive Surgical for their executive compensation structures, though the specific number of options and exercise price would depend on company size, market capitalization, and compensation philosophy.

Related Party Transactions

• The grant of stock options to the Chief Executive Officer is a transaction between the company and a related party (executive management), which is a standard form of executive compensation.

Stakeholder Impact

• Shareholders: Potential future dilution if options are exercised, but also potential for increased shareholder value if the CEO's incentives lead to improved company performance.
• Employees: May signal confidence in leadership and potentially set a precedent for other employee equity compensation.

Next Steps

• Vesting of 50% of options on August 6, 2026.
• Quarterly vesting of remaining 50% over the subsequent three years.
• Full vesting of options by August 6, 2029.
• Potential exercise of options by Jennifer Ernst before August 5, 2035, subject to vesting.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to the CEO as part of her compensation package. While it aligns management's interests with shareholders and provides a long-term incentive, it does not provide new fundamental information about the company's financial performance, strategic direction, or market position that would warrant a change in investment recommendation. Investors should consider this a standard operational disclosure rather than a catalyst for significant price movement.

Keywords

Tivic Health Systems, TIVC, Jennifer Ernst, Stock Options, CEO, Director, SEC Form 4, Equity Compensation, Insider Transaction